1-11796340-CCTT-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The ENST00000376590.9(MTHFR):βc.643_645delβ(p.Lys215del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,248 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.0000066 ( 0 hom., cov: 32)
Exomes π: 6.8e-7 ( 0 hom. )
Consequence
MTHFR
ENST00000376590.9 inframe_deletion
ENST00000376590.9 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.30
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in ENST00000376590.9. Strenght limited to Supporting due to length of the change: 1aa.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFR | NM_005957.5 | c.643_645del | p.Lys215del | inframe_deletion | 5/12 | ENST00000376590.9 | NP_005948.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFR | ENST00000376590.9 | c.643_645del | p.Lys215del | inframe_deletion | 5/12 | 1 | NM_005957.5 | ENSP00000365775 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251490Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135918
GnomAD3 exomes
AF:
AC:
2
AN:
251490
Hom.:
AF XY:
AC XY:
1
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461040Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 726852
GnomAD4 exome
AF:
AC:
1
AN:
1461040
Hom.:
AF XY:
AC XY:
1
AN XY:
726852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74362
GnomAD4 genome
AF:
AC:
1
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Homocystinuria due to methylene tetrahydrofolate reductase deficiency Pathogenic:1Uncertain:1
Pathogenic, no assertion criteria provided | clinical testing | University Children's Hospital, University of Zurich | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This variant, c.643_645del, results in the deletion of 1 amino acid(s) of the MTHFR protein (p.Lys215del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs746353274, gnomAD 0.002%). This variant has been observed in individual(s) with severe methylenetetrahydrofolate reductase deficiency or homocystinuria (PMID: 25736335, 27768236). ClinVar contains an entry for this variant (Variation ID: 187878). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 06, 2021 | Variant summary: MTHFR c.643_645delAAG (p.Lys215del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 8e-06 in 251490 control chromosomes. c.643_645delAAG has been reported in the literature in individuals affected with Homocystinuria Due To Methylene Tetrahydrofolate Reductase Deficiency. In one case, the variant was reported in a patient with hyperhomocysteinemia who had less than 1.5% residual MTHFR activity in cultured fibroblasts cell lines, but also carried an additional MTHFR variant (c.391C>T), making conclusions about the functional significance of the variant of interest difficult to assess (Bruda_2015). Additonally, the variant was reported in a patient referred for pharmacogenetic analysis prior to chemotherapy initiation, who also displayed hyperhomocysteinemia (Palmirotta_2017). The patient also carried c.677C>T and c.1298A>C, variants known to be associated wiht decreased enzyme activity. Segregation studies showed the probands daughter to carry all three variants and displayed similar hyperhomocysteinemia, while the probands son carried only c.1298A>C as well as the variant of interest, and had normal biochemical values. Thus the authors concluced that the increased plamsa tHcy appeared to be most likely related to the c.677C>T variant, and that the c.643_645delAAG is not suggestive of a pathogenic effect. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at